Pan-cancer analyses demonstrated MYO9A may have a protective role in the occurrence and progression of various human cancers.<h4>Conclusion</h4>RA might be associated with a slight increased risk of CRC. This evidence concerns the gene MYO9A and colorectal carcinoma.